Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
about
In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.TNF-α inhibitory effect of Euphorbia hirta in rats.CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.Percentage of Memory B Lymphocytes and Regulatory T Lymphocytes in Peripheral Blood are Low but Not Predictive of Therapy outcomes in Newly Diagnosed Adult Patients with Primary Immune Thrombocytopenia.
P2860
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@en
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@nl
type
label
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@en
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@nl
prefLabel
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@en
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@nl
P2860
P31
P921
P356
P1476
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis.
@en
P2093
Maria J Leandro
P2860
P2888
P356
10.1186/AR2809
P577
2009-10-06T00:00:00Z
P5875
P6179
1047290010